Google Defines “Big” as large, sizable, great, huge, immense, enormous, extensive, vast, titanic, massive, more and more.
Would it be correct to assume that because one organization is larger than another that it has the capability to deliver more success than smaller companies? Fortunately or unfortunately big pharma is catching on to this. According to recent reports, it seems that large contract research organizations (CROs) may be falling by the wayside. They seem to be becoming a thing of the past. They lay between being too big to partner with large pharmaceuticals companies, yet missing the capabilities of much larger CROs that were created through merger and acquisition. What we see on the flip is that mid-sized and smaller CROs continue to flourish.
Small CROs, because of their niche/indication, are able to strengthen their status as the CRO partner of choice for small pharma/biotech/medical device. While the CRO giants may have the infrastructure required to conduct large scale studies, we are beginning to see shift in questioning by big pharma. Can these organizations offer the same level of service and management often provided by smaller CRO’s? For example, smaller organizations are able to quickly assemble experienced team members and angle themselves to fit requirements of a protocol. Larger CRO’s can often find themselves handcuffed by processes and multiple layers of decision making management.
This all leads to Investigators stepping out of their comfort zone for CRO selection. Since there will always be new, competitive, regulatory and economic challenges, pharma companies are considering their options when it comes to choosing a CRO who is capable of the job.
With regard to workforce, many mid-sized and smaller CROs were founded and are run by the groups of qualified staff who started to organization and are experts in their therapeutic area. This gives them the competitive advantage. Larger CROs are normally made up of hired experts in varying levels of therapeutics.
Ultimately investigators want to use a CRO as an extension of their team. They look to form a successful partnership. Though “CV” experience is paramount it can only demonstrate so much. Investigators are increasingly selecting CRO partners they can build collaborative relationships with to help face the challenges in this ever changing environment.
If you would like to discuss this, feel free to contact Vinny Napoli at 727-544-4842 today!